Anebulo Pharmaceuticals Inc

NASDAQ ANEB

Download Data

Anebulo Pharmaceuticals Inc Dividend Payout Ratio 1 year YoY Change (%) for the year ending September 19, 2024

Anebulo Pharmaceuticals Inc Dividend Payout Ratio 1 year YoY Change (%) is NA for the year ending September 19, 2024. The dividend payout ratio measures the percentage of a company's net income that is distributed as dividends to shareholders. It is calculated by dividing dividends paid by net income. This ratio provides insights into the portion of earnings that is returned to shareholders in the form of dividends. A higher ratio indicates a larger proportion of earnings being paid out as dividends. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • Anebulo Pharmaceuticals Inc Dividend Payout Ratio for the year ending December 31, 2021 was -27.12%.
NASDAQ: ANEB

Anebulo Pharmaceuticals Inc

CEO Dr. Joseph F. Lawler M.D., Ph.D.
IPO Date May 7, 2021
Location United States
Headquarters 1415 Ranch Road 620 South, Lakeway, TX, United States, 78734
Employees 2
Sector Healthcare
Industry Biotechnology
Description

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.

Similar companies

ADAG

Adagene Inc

NA

NA

ACRV

Acrivon Therapeutics Inc. Common Stock

NA

NA

AVTE

Aerovate Therapeutics Inc

NA

NA

ANTX

AN2 Therapeutics Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email